List of articles in "Drug" category - Page 502

Conivaptan (YM 087 brand name Vaprisol) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist). It was approved in 2004 for hyponatremia (low blood sodium levels) caused by syndrome […]

Lumiracoxib (rINN) is a carboxylic acid COX-2 selective inhibitor non-steroidal anti-inflammatory drug manufactured by Novartis and still sold in few countries including Mexico Ecuador and the Dominican Republic under the […]

Etoricoxib (brand name Arcoxia worldwide; Coxyveen by Solmarc and Nucoxia in India also Algix and Tauxib in Italy Vargus by Sandoz in Bangladesh Starcox By GETS Pharma in Pakistan Exxiv […]

Acitretin (trade name Soriatane or Neotigason) is a second-generation retinoid. It is taken orally and is typically used for psoriasis.It is a metabolite of etretinate which was used prior to […]

Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic […]

Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. It was previously known as 506U78. Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate […]

Fluorouracil /flʊoʊroʊʊræsɪl/ or 5-FU (trademarked as Adrucil (IV) Carac (topical) Efudex (topical)) is a drug that is a pyrimidine analog which is used in the treatment of cancer. It is […]

Idarubicin /ˌaɪdəˈruːbɨsɪn/ or 4-demethoxydaunorubicin is an anthracycline antileukemic drug. It inserts itself into DNA and prevents DNA from unwinding by interfering with the enzyme topoisomerase II. It is an analog […]

2-Methoxyestradiol (2ME2) is a natural metabolite of estradiol. As an experimental drug candidate it is being developed under the tradename of Panzem.

Pralatrexate (brand name Folotyn) is an anti-cancer therapy. It is the first drug approved as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma or PTCL — a […]